New FDA Approved Overactive Bladder Medicine

Overactive Bladder Help

An overactive bladder leaves you feeling anything but healthy or attractive, but the Food and Drug Administration (FDA) has approved a new drug to help. Mirabegron, sold under the name Myrbetriq, helps with uncontrollable bladder muscles, according to a press release.

How Myrbetric Works

Myrbetric works by improving the bladder's storage capacity and relaxing the bladder muscle while filling. This halts uncontrollable and unexpected squeezing. The test group of over 4,000 patients provided information about Mybetric's effectiveness in cutting the number of wetting accidents and the number of daily trips to the restroom.

Here is what this means to patients taking this newly approved bladder control medication:

• Reduced urinary frequency: This means you won't need to run to the restroom as often. It also means you get a good night's sleep, leaving you looking refreshed and healthy because your bladder will not wake you up every couple of hours.
• Reduced urinary urgency: This means you get a bit more warning before you have to go to the restroom.
• Less chance of urinary leakage: This means you do not have to spend as much money on incontinence pads or as much time dealing with unexpected leaks.

If you have an overactive bladder, do not feel alone. In America alone, about 33 million people suffer from this condition. At best, dealing with bladder issues leaves individuals frustrated. At worst, the condition becomes debilitating.

The pre-approval study did find a few side effects associated with taking Myrbetric including:

• Increased blood pressure
• Common cold-like symptoms, called nasopharyngitis
• Urinary tract infection
• Constipation
• Fatigue
• Elevated heart rate, called tachycardia
• Abdominal pain

Not all overactive bladder patients can take Myrbetriq. According to the FDA, patients with severe, uncontrolled high blood pressure, end stage kidney disease, and severe liver impairment should avoid this medication.